Mark L. Bagarazzi

590 citations
6 papers · 456 indexed · h-index 4
Topics
Immunotherapy and Immune Responses (4 papers)vaccines and immunoinformatics approaches (2 papers)HIV Research and Treatment (2 papers)
Partner nations
United States

In The Last Decade

Mark L. Bagarazzi

5 papers receiving 435 citations

Peers

Mark L. Bagarazzi
Comparison fields: 5 of 41
  • Immunology 296
  • Virology 209
  • Molecular Biology 174
  • Epidemiology 134
  • Infectious Diseases 90
Replace Michael Merva with:
Michael Merva United States
Florence Boudet France
Mary S. Wu United States
Maria Luisa Visciano United States
Lori Gilbert United States
Minh H. Tran United States
P. Azadnia United States
Lautaro G. Perez United States
Marie Rojas France
Veronica Neumann United States
Mark L. Bagarazzi relative to Michael Merva United States Michael Merva's profile →
Citations per field
00.5×11×
Michael Merva · 1×
Citations per year

Countries citing papers authored by Mark L. Bagarazzi

Since Specialization
Citations

This map shows the geographic impact of Mark L. Bagarazzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark L. Bagarazzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark L. Bagarazzi more than expected).

Fields of papers citing papers by Mark L. Bagarazzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark L. Bagarazzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark L. Bagarazzi. The network helps show where Mark L. Bagarazzi may publish in the future.

Co-authorship network of co-authors of Mark L. Bagarazzi

This figure shows the co-authorship network connecting the top 25 collaborators of Mark L. Bagarazzi. A scholar is included among the top collaborators of Mark L. Bagarazzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark L. Bagarazzi. Mark L. Bagarazzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
#WorkIndexed citations
1 0
2 7
3 1
4 57
5 91
6 300

About Mark L. Bagarazzi

Mark L. Bagarazzi is a scholar working on Virology, Immunology and Biotechnology, having authored 6 papers that have together received 456 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (4 papers), vaccines and immunoinformatics approaches (2 papers) and HIV Research and Treatment (2 papers). The work is most often cited by research in Virology (209 citations), Immunology (296 citations) and Infectious Diseases (90 citations). Mark L. Bagarazzi has collaborated with scholars based in United States. Frequent co-authors include David B. Weiner, Jean Boyer, Kenneth E. Ugen, Richard B. Ciccarelli, Michael A. Chattergoon, Yosef Refaeli, William V. Williams, Patrice A. Frost, Ali Javadian and Michael G. Agadjanyan. Their work appears in journals such as Nature Medicine, Journal of Clinical Oncology and Vaccine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026